Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.36
-0.80 (-9.80%)
At close: Nov 3, 2025, 4:00 PM EST
7.74
+0.38 (5.16%)
After-hours: Nov 3, 2025, 4:38 PM EST
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $86.75 million as of November 3, 2025. Its market cap has increased by 33.85% in one year.
Market Cap
86.75M
Enterprise Value
71.01M
1-Year Change
33.85%
Ranking
Category
Stock Price
$7.36
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $86.75M, a decrease of -89.85%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 86.75M | 196.82% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |